FDA Approves ONDANSETRON — Dr. Reddy's Laboratories Limited

# FDA Approves Dr. Reddy's Laboratories' Generic Ondansetron Dr. Reddy's Laboratories Limited received FDA approval for its generic ondansetron hydrochloride oral formulation, expanding the competitive landscape in the anti-nausea medication market and providing patients with a more affordable treatment option for chemotherapy-induced nausea and vomiting. The approval of this cost-effective generic alternative is expected to capture significant market share from branded versions and drive down prices across the therapeutic category.